AbbVie (NYSE: ABBV) has long been known for its immunology drugs like Humira, which at one point was the top-selling drug in ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Here’s a set of numbers that so far haven’t been revised: The U.S. economy has added 486,000 jobs during Trump’s second term, ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Uber CEO Dara Khosrowshahi revealed that the company is actively engaging private equity firms and banks to secure funding ...

Lucid Group reported disappointing second-quarter results, with revenue of $259.4 million, missing analyst estimates of ...

Leading the charge this morning is Smith & Nephew PLC (LSE:SN), up over 11% after the knee- and hip-replacement group ...

US stocks pushed higher on Wednesday amid another batch of corporate earnings and as President Trump's new deadline to impose ...

Glencore Earnings Fall on Lower Coal Prices, Copper Production Challenges The commodities giant said the results reflect lower coal prices and a drop in copper production following operational ...

Rivian largely blamed a tapering in the value of U.S. regulatory credits - expected to be about half of the $300 million it ...

China’s curbs on heavy rare earth metal export sharply increased material costs, driving up cost of U.S. EV production ...

For the year-to-date ending in July, Tesla (NASDAQ: TSLA) sold 10,000 vehicles, 57.8% less than the same period in 2024.